Historical position

Millennium Management LLC’s Pfizer (PFE) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Millennium Management LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2021Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares19.92MHighest verified quarter-end share count
Quarters reported10Verified quarters with shares above zero
What happened?

Millennium Management LLC first reported Pfizer in Q3 2021. The reported position was increased and reduced across later filings. Verified positive position history runs through Q2 2025. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2025
Bought 87.6% more+6.53M shares · 13.99M shares reported after the change
Filing context

Quarter-end price $24.24

Q1 2025
Bought 145.5% more+4.42M shares · 7.46M shares reported after the change
Filing context

Quarter-end price $25.34

Q3 2024
Sold 22.3% of the position−4.45M shares · 15.47M shares remained
Filing context

Quarter-end price $28.94

Q2 2024
Bought 156.2% more+12.15M shares · 19.92M shares reported after the change
Filing context

Quarter-end price $27.98

Q1 2024
Sold 18.5% of the position−1.76M shares · 7.78M shares remained
Filing context

Quarter-end price $27.75

Q4 2023
Bought 124.2% more+5.28M shares · 9.54M shares reported after the change
Filing context

Quarter-end price $28.79

Portfolio importance

How important was Pfizer in Millennium Management LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.2%Q2 2025
Last reported rank#75Rank unavailable
Peak portfolio weight0.3%Q2 2024
Best historical rank#46Q2 2024
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$28.412026-09-24

Market context only; not an investor transaction price.

Latest filing quarter-end price$24.24Q2 2025

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

View Pfizer stock page →

This is a bounded selection from a 13F combination report. A portion is reported separately by another manager. The profile does not represent all investments, trades or performance. Quarters are reporting observations, not transaction dates.